Rincon D, Lo Iacono O, Ripoll C, Gomez-Camarero J, Salcedo M, Catalina M V, Hernando A, Clemente G, Matilla A, Nuñez O, Bañares R
Sección de Hepatología, Servicio de Aparato Digestivo, Hospital Gregorio Marañon, Madrid, Spain.
Aliment Pharmacol Ther. 2007 Apr 1;25(7):841-8. doi: 10.1111/j.1365-2036.2007.03258.x.
Hepatic venous pressure gradient (HVPG) has prognostic value in complications and survival of patients with liver cirrhosis. However, the relationship between HVPG and the outcome of acute alcoholic hepatitis (AAH), as well as the specific features of portal hypertension syndrome in this setting, have not been defined.
To evaluate the prognostic value of HVPG and to analyse the degree of portal hypertension and hyperdynamic circulation in patients with severe AAH.
Early measurements of HVPG were performed in 60 patients with severe AAH, and compared with the haemodynamic findings of 37 and 29 liver transplantation candidates with alcoholic or viral end-stage cirrhosis respectively.
Twenty-three patients (38%) died during hospitalization. Portal hypertension and hyperdynamic circulation were more severe in AAH patients. HVPG was greater in non-survivors [26.9 (7.4) vs. 19.4 (5.2) mmHg, P < 0.001]. Only 4/31 (13%) patients with HVPG <or= 22 mmHg died from the episode of AAH, vs. 19/29 (66%) patients with HVPG > 22 (P < 0.001). Encephalopathy (OR 9.4; CI 1.4-64.8), Model for End-Stage Liver Disease (MELD) score > 25 (OR 7.4; CI 1.4-39.9) and HVPG > 22 mmHg (OR 6.7; CI 1.1-39.9) were independently associated to in-hospital mortality.
Early measurement of HVPG provides important prognostic information on the short-term outcome of patients with severe AAH. In addition, MELD score also seems to be a strong prognostic factor in these patients.
肝静脉压力梯度(HVPG)对肝硬化患者的并发症及生存情况具有预后价值。然而,HVPG与急性酒精性肝炎(AAH)预后之间的关系,以及在此情况下门静脉高压综合征的具体特征尚未明确。
评估HVPG的预后价值,并分析重症AAH患者的门静脉高压程度及高动力循环情况。
对60例重症AAH患者进行HVPG早期测量,并分别与37例酒精性终末期肝硬化和29例病毒性终末期肝硬化的肝移植候选者的血流动力学结果进行比较。
23例患者(38%)在住院期间死亡。AAH患者的门静脉高压和高动力循环更为严重。非存活者的HVPG更高[26.9(7.4)对19.4(5.2)mmHg,P<0.001]。HVPG≤22 mmHg的患者中只有4/31(13%)死于AAH发作,而HVPG>22 mmHg的患者中有19/29(66%)死亡(P<0.001)。肝性脑病(OR 9.4;CI 1.4 - 64.8)、终末期肝病模型(MELD)评分>25(OR 7.4;CI 1.4 - 39.9)和HVPG>22 mmHg(OR 6.7;CI 1.1 - 39.9)与院内死亡率独立相关。
HVPG的早期测量为重症AAH患者的短期预后提供了重要的预后信息。此外,MELD评分似乎也是这些患者的一个强有力的预后因素。